Eye study underscores the long-lasting benefits of controlling diabetes

NIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control.

People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy. Investigators who led the ACCORD Follow-on Eye Study (ACCORDION) announced the results today in New Orleans at the American Diabetes Association annual meeting. The study was supported by the National Institutes of Health’s National Eye Institute (NEI).

Dr. Emily Chew, deputy director of the NEI Division of Epidemiology and Clinical Applications, gives a female patient an eye exam.

Read more View All News

This page was last updated on Friday, January 21, 2022